New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 8, 2012
07:57 EDTCRTXCornerstone Therapeutics on track to achieve in excess of $8M in EKR synergies
CEO Craig A. Collard commented: "The integration of EKR Therapeutics was completed successfully and rapidly, well ahead of our plans, and we are on track to achieve in excess of $8 million in synergies during 2H of 2012. We plan to use our positive momentum to seek out additional acquisition opportunities to fuel our growth."
News For CRTX From The Last 14 Days
Check below for free stories on CRTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CRTX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use